CoChat

Morning or Bedtime NPH Insulin Combined With Sulfonylurea in Treatment of NIDDM

Groop, Leif C, Widén, Elisabeth, Ekstrand, Agneta, Saloranta, Carola, Franssila-Kallunki, Anja, Schalin-Jäntti, Camilla, Eriksson, Johan G · 1992 · Diabetes Care
Cited by 35

The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.

Abstract

Objective: To compare the effect of morning and bedtime NPH insulin combined with daytime sulfonylurea on glycemic control in non-insulin-dependent diabetes mellitus (NIDDM) patients no longer responding to treatment with sulfonylureas alone. Research Design and Methods: Twenty-four NIDDM patients who fulfilled these criteria were randomized to treatment with Protaphan human insulin in the morning or at bedtime (22 ± 1 IU) plus 3.5 mg glibenclamide twice a day. Results: Morning and bedtime NPH insulin resulted in equal reduction of HbA1 (from 13.5 ± 0.3 to 9.4 ± 0.1 and 9.6 ± 0.2%, respectively) and mean self-monitored blood glucose (9.2 ± 0.5 vs. 10.1 ± 0.4 mM). Bedtime insulin resulted in lower morning blood glucose (7.8 ± 0.5 vs. 9.1 ± 0.4 mM; P < 0.01), whereas morning insulin resulted in lower evening blood glucose (10.1 ± 0.6 vs 12.1 ± 0.6 mM, P < 0.01). Conclusions: Morning and bedtime NPH insulin combined with glibenclamide are equipotent in the treatment of NIDDM patients with secondary failure to sulfonylurea. However, this treatment regimen normalizes blood glucose only in a small group of patients. Therefore, more intensified insulin therapy seems to be required to achieve this goal.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.2337/diacare.15.7.831

Cites

2 of 2 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Cited by

See all 35

Metadata

Authors
Groop, L. C., Widén, E., Ekstrand, A., Saloranta, C., Franssila-Kallunki, A., Schalin-Jäntti, C., & Eriksson, J. G.
Venue
Diabetes Care
Published
1992-07-01
Volume
15
Issue
7
Pages
831-834
ISSN
  • 0149-5992 (ISSN-L)
  • 1935-5548
OpenAlex
W1990583584
Cited by
35
References
2
FWCI
1.65
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.